Health Implications of Lipedema: Analysis of Patient Questionnaires and Population-Based Matched Controls.
Volume: 14
Issue: 3
Year of Publication:
Abstract summary
We conducted a comparative study involving 39 female patients with lipedema and group-matched controls at a ratio of 1:5. The primary survey tool was the German Health Update (GEDA 2019/2020-EHIS) questionnaire, which was developed by the Robert Koch Institute (RKI), Germany. The secondary survey tool was the German Pain Questionnaire. The prevalence of hypertension ( = 0.041) and high blood lipids ( = 0.024) was lower in the lipedema group compared to the control group. General health and well-being indicators demonstrated lower overall health ratings ( < 0.001) and higher physiotherapy use in patients with lipedema ( = 0.016). Mental health assessment revealed higher depression prevalence and severity ( = 0.001), together with a lower number of close contacts ( = 0.032). Furthermore, patients with lipedema experienced higher levels of pain ( < 0.001) and more significant pain-related disability in daily activities ( < 0.001) than controls. Correlation analysis among patients with lipedema showed a positive correlation between pain severity and depressive symptoms (ρ = 0.612, < 0.001) and a moderate positive correlation with impaired health-related quality of life (ρ = 0.418, = 0.010). In summary, our findings highlight significant differences in health and well-being between patients with lipedema and matched controls, especially in overall, metabolic, and mental health, as well as pain perception. The findings emphasize the need for a validated lipedema-specific questionnaire and a multidisciplinary treatment approach with a combination of physical therapies, lifestyle adjustments, and psychological strategies.Study Outcome
Source Link: Visit source
Statistics
Citations : Herbst K.L., Kahn L.A., Iker E., Ehrlich C., Wright T., McHutchison L., Schwartz J., Sleigh M., Donahue P.M., Lisson K.H., et al. Standard of care for lipedema in the United States. Phlebology. 2021;36:779–796. doi: 10.1177/02683555211015887.Authors : 7
Identifiers
Doi : 295SSN : 2075-1729